[
    [
        {
            "time": "2018-07-23",
            "original_text": "疫苗事件持续发酵，多家基金公司下调康泰生物估值。",
            "features": {
                "keywords": [
                    "疫苗事件",
                    "基金公司",
                    "康泰生物",
                    "估值下调"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "疫苗事件持续发酵，多家基金公司下调康泰生物估值。",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-07-24",
            "original_text": "疫苗风波杀伤力有多大？今天有人巨亏26%。",
            "features": {
                "keywords": [
                    "疫苗风波",
                    "杀伤力",
                    "巨亏"
                ],
                "sentiment_score": -0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "疫苗风波杀伤力有多大？今天有人巨亏26%。",
                "Correlation": 7,
                "Sentiment": 2,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-07-25",
            "original_text": "康泰生物回应股价暴跌：公司产品质量稳定，经营有序。",
            "features": {
                "keywords": [
                    "康泰生物",
                    "股价暴跌",
                    "产品质量",
                    "经营有序"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物回应股价暴跌：公司产品质量稳定，经营有序。",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-07-26",
            "original_text": "中银基金：下调康泰生物的估值至42.25元/股，相当于三个跌停。",
            "features": {
                "keywords": [
                    "中银基金",
                    "康泰生物",
                    "估值下调",
                    "三个跌停"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "中银基金：下调康泰生物的估值至42.25元/股，相当于三个跌停。",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-07-27",
            "original_text": "国务院对疫苗事件派出调查组！长生生物市值蒸发近百亿，对医药股影响几何？",
            "features": {
                "keywords": [
                    "国务院",
                    "疫苗事件",
                    "调查组",
                    "长生生物",
                    "市值蒸发",
                    "医药股"
                ],
                "sentiment_score": -0.95,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "国务院对疫苗事件派出调查组！长生生物市值蒸发近百亿，对医药股影响几何？",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-07-30",
            "original_text": "自媒体文章牵出康泰生物，董秘：疫苗从未有质量问题。",
            "features": {
                "keywords": [
                    "自媒体",
                    "康泰生物",
                    "疫苗",
                    "质量问题"
                ],
                "sentiment_score": 0.1,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "自媒体文章牵出康泰生物，董秘：疫苗从未有质量问题。",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]